| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/24/1997 | WO1997026326A1 Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use |
| 07/24/1997 | WO1997026324A1 Solid phase enrichment of intact cells using intracellular constituents |
| 07/24/1997 | WO1997026318A1 Soaps produced from high laurate canola oil-based fatty acids |
| 07/24/1997 | WO1997026272A1 Leptin receptor variants |
| 07/24/1997 | WO1997026023A1 Wound dressing and apparatus |
| 07/24/1997 | WO1997026010A1 Anticoagulant agents useful in treatment of thrombosis |
| 07/24/1997 | WO1997026009A1 Compounds capable of inhibiting hiv-1 infection |
| 07/24/1997 | WO1997026000A1 Therapeutic applications of t-bam (cd40-l) technology to treat inflammatory kidney diseases______________________________________ |
| 07/24/1997 | WO1997025999A1 Peptides for altering osteoblast adhesion |
| 07/24/1997 | WO1997025861A1 H2-m modified transgenic animals |
| 07/24/1997 | WO1997025860A1 Cellular immunogens useful as cancer vaccines |
| 07/24/1997 | WO1997018300A3 Murine model for human carcinoma |
| 07/24/1997 | WO1997014808A3 Herpesvirus vectors and their uses |
| 07/24/1997 | WO1997007198A3 Dna sequences and secreted proteins encoded thereby |
| 07/24/1997 | WO1997006176A3 Peptide and o-glycan inhibitors of selectin mediated inflammation |
| 07/24/1997 | CA2844461A1 Compositions for treating anemia |
| 07/24/1997 | CA2248638A1 Methods and compositions for inhibiting hexokinase |
| 07/24/1997 | CA2243531A1 Therapeutic applications of t-bam (cd40-l) technology to treat inflammatory kidney diseases______________________________________ |
| 07/24/1997 | CA2243470A1 Recombinant aav virion for expressing epo in a mammal |
| 07/24/1997 | CA2243446A1 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 07/24/1997 | CA2243300A1 Compositions and methods for modulating cell proliferation using growth factor-polysaccharide binding fusion proteins |
| 07/24/1997 | CA2243268A1 Anthranilate synthase gene and use thereof |
| 07/24/1997 | CA2243197A1 Solid phase enrichment of intact cells using intracellular constituents |
| 07/24/1997 | CA2242911A1 Peptides for altering osteoblast adhesion |
| 07/24/1997 | CA2242400A1 H2-m modified transgenic animals |
| 07/24/1997 | CA2241952A1 Cellular immunogens useful as cancer vaccines |
| 07/23/1997 | EP0785432A1 Method for the immunological identification or determination of polypeptide antigens |
| 07/23/1997 | EP0785274A1 An artifical recombinant substrate (rAGG-1) and native aggrecan to study the proteolytic activity of 'Aggrecanase' in cell culture systems |
| 07/23/1997 | EP0785273A1 Paired basic amino acid converting enzyme and DNA sequence encoding it |
| 07/23/1997 | EP0785272A1 Prolyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785271A1 Threonyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785269A1 Histidyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785267A1 Valyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785266A1 Arginyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785265A1 Aspartyl tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785264A1 Lencyl t-RNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785263A1 Tryptophanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785262A1 Phenylalanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785261A1 Glutamyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785259A1 Asparaginyl t-RNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785258A1 Staphylococcus aureus tyrosyl-tRNA synthetase |
| 07/23/1997 | EP0785254A2 Phosphatidyl-ionsitol glycan class F (PIG-F), the cDNA encoding it and their use as medicament |
| 07/23/1997 | EP0785216A1 Chomosome 13-linked breast cancer susceptibility gene BRCA2 |
| 07/23/1997 | EP0784693A1 Viral vectors and line for gene therapy |
| 07/23/1997 | EP0784690A1 Complementary adenoviral vector systems and cell lines |
| 07/23/1997 | EP0784688A1 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 07/23/1997 | EP0784685A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 07/23/1997 | EP0784683A1 Tie-2 ligands, methods of making and uses thereof |
| 07/23/1997 | EP0784682A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 07/23/1997 | EP0784680A1 Dna coding for a zinc finger protein, a zinc finger protein and the use thereof |
| 07/23/1997 | EP0784677A1 Inhibitor of stem cell proliferation and uses thereof |
| 07/23/1997 | EP0784673A1 A method of selecting pluripotent hematopoietic progenitor cells |
| 07/23/1997 | EP0784672A1 Human inositol monophosphatase h1 |
| 07/23/1997 | EP0784631A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 07/23/1997 | EP0784499A1 Artificial liver apparatus and method |
| 07/23/1997 | EP0784483A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 07/23/1997 | EP0784423A1 Plants with delayed or inhibited ripening or senescence |
| 07/23/1997 | EP0675964B1 HUMAN CYCLOOXYGENASE-2cDNA AND ASSAY FOR EVALUATING INHIBITION OF CYCLOOXYGENASE-2 |
| 07/23/1997 | EP0654092A4 Method for detecting pre-cancerous or cancerous cells using p90 antibodies or probes. |
| 07/23/1997 | EP0649464B1 Transfection of vertebrate cells e.g. by homologous recombination |
| 07/23/1997 | EP0502968B1 Activatable fibrinolytic and anti-thrombotic proteins |
| 07/23/1997 | EP0474846B1 Polypeptides with a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides to screen active substances on these polypeptides |
| 07/22/1997 | US5650559 Male sterile plant species |
| 07/22/1997 | US5650555 Transgenic plants producing polyhydroxyalkanoates |
| 07/22/1997 | US5650492 P-40 homodimer of interleukin-12 |
| 07/22/1997 | US5650324 Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase |
| 07/22/1997 | US5650318 Process and culture medium for the production of cells infected by a multiple sclerosis-associated virus |
| 07/22/1997 | US5650317 Human breast epithelial cell type with stem cell and luminal epithelial cell characteristics |
| 07/22/1997 | US5650307 Human serum albumin produced by growing transgenic plants or cells with genome recombitant dna sequence |
| 07/22/1997 | US5650300 Method of producing monoclonal antibodies to oncofetal protein |
| 07/22/1997 | US5650299 Cells producing stem cell proliferation factor |
| 07/22/1997 | US5650298 Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
| 07/22/1997 | US5650293 Nucleic acid encoding pp60PIK and the methods of making pp60PIK |
| 07/22/1997 | US5650286 Genomic DNA of human cholesterol 7α-hydroxylase and methods for using it |
| 07/22/1997 | US5650164 Process for preparing artificial skin with biocompatible perforated membranes |
| 07/22/1997 | US5650147 Administering a cytokine |
| 07/22/1997 | US5650135 Non-invasive localization of a light-emitting conjugate in a mammal |
| 07/19/1997 | CA2193717A1 Process for identification or immunologic determination of polypeptidic antigens |
| 07/17/1997 | WO1997025617A1 Method for evaluating keratinocyte migration |
| 07/17/1997 | WO1997025446A1 Recombinase-mediated generation of adenoviral vectors |
| 07/17/1997 | WO1997025430A1 Calcium binding proteolipid compositions and methods |
| 07/17/1997 | WO1997025428A1 Apo-2 ligand |
| 07/17/1997 | WO1997025425A1 Wsx receptor and ligands |
| 07/17/1997 | WO1997025424A1 Ob protein receptor and related compositions and methods |
| 07/17/1997 | WO1997025420A1 Expression augmenting sequence elements (ease) for eukaryotic expression systems |
| 07/17/1997 | WO1997025417A1 Glycosidase enzymes |
| 07/17/1997 | WO1997025414A1 Delivery of bioactive compounds to an organism |
| 07/17/1997 | WO1997025413A1 Ungulate embryonic stem-like cells, making and using the cells to produce a transgenic ungulate |
| 07/17/1997 | WO1997025412A1 Ungulate embryonic stem-like cells, methods of making and using the cells to produce transgenic ungulates |
| 07/17/1997 | WO1997025410A1 A method for in vivo production of a mutant library in cells |
| 07/17/1997 | WO1997025351A2 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR |
| 07/17/1997 | WO1997025341A1 Novel amp activated protein kinase |
| 07/17/1997 | WO1997025339A1 Composition and method for delivery of nucleic acids |
| 07/17/1997 | WO1997025068A2 Mesothelin antigen and methods and kits for targeting it |
| 07/17/1997 | WO1997025058A1 Stable biocatalysts for ester hydrolysis |
| 07/17/1997 | WO1997009428A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/17/1997 | DE19601365A1 Nucleinsäuremoleküle aus Pflanzen codierend Enzyme, die an der Stärkesynthese beteiligt sind Nucleic acid molecules encoding enzymes from plants, which are involved in starch synthesis |
| 07/17/1997 | CA2666263A1 Apo-2 ligand |
| 07/17/1997 | CA2242864A1 Stable biocatalysts for ester hydrolysis |
| 07/17/1997 | CA2242711A1 Delivery of bioactive compounds to an organism |